Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full Approval for Treating IgA Nephropathy
Shots: The US FDA has granted full approval to Filspari (400mg) for treating IgAN,...
Shots: The US FDA has granted full approval to Filspari (400mg) for treating IgAN,...
Shots: The US FDA has granted orphan drug designation to the company’s certe...
Shots: The EC has granted orphan drug designation to VTX-806, an adeno-associated...
Shots: The US FDA has accepted NDA for sebetralstat to treat HAE (PDUFA: Jun 17, 2...
Shots: The US FDA has granted clearance to the company’s IND application for...
Shots: The EC has approved Braftovi + Mektovi to treat advanced NSCLC adults with...
Incisive News in 3 Shots.